Skip to main content
SpringerLink
Log in

Breast cancer risk communication: challenges and future research directions: workshop report (United States)

  • Published:
Cancer Causes & Control Aims and scope Submit manuscript

Abstract

The Dana-Farber Harvard Cancer Center and the Harvard Center for Cancer Prevention convened a conference in May 2002 to review the current issues in breast cancer risk communication and to identify directions for future research. Specific topics included risk communication theory, use of risk models in breast cancer screening, genetic testing, decision-making regarding breast cancer treatment, and the role of popular media in risk communication. This report describes the proceedings of the conference.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jemal A,Thomas A,Murray T, et al. (2002) Cancer statistics, 2002. CA Cancer J Clin 52: 23-47.

    Google Scholar 

  2. Ovretveit J (1996) Informed choice? Health service quality and outcome information for patients. Health Policy 37: 75-90.

    Google Scholar 

  3. Neuberger J (2000) The educated patient: new challenges for the medical profession. J Intern Med 247: 6-10.

    Google Scholar 

  4. Fischhoff B,Bostrom A,Quadrel MJ (2000) Risk perception and communication. In: Detels R,McEwen R,Beaglehole R,Tanaka H, eds. Oxford Textbook of Public Health, London: Oxford University Press, pp. 987-1002.

    Google Scholar 

  5. Fischhoff B (1999) Why (cancer) risk communication can be hard. Monogr J Natl Cancer Inst 25: 7-13.

    Google Scholar 

  6. National Institutes of Health Consensus Development Panel(1997) NIH Consensus Conference Statement: Breast cancer screening for women 40-49. Monogr J Natl Cancer Inst 22: vii-xviii.

    Google Scholar 

  7. Gail MH,Brinton LA,Byar DP, et al. (1989) Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81: 1879-1996.

    Google Scholar 

  8. Claus EB,Risch N,Thompson WD (1994) Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73: 643-651.

    Google Scholar 

  9. Couch FJ,DeShano ML,Blackwood MA, et al. (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409-1415.

    Google Scholar 

  10. Shattuck-Eidens D,McClure M,Simard J, et al. (1995) A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene: implications of presymptomatic testing and screening. JAMA 273: 535-541.

    Google Scholar 

  11. Frank TS,Manley SA,Olopade OI, et al. (1998) Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. J Clin Oncol 16: 2417-2425.

    Google Scholar 

  12. Berry DA,Iversen ES,Gudbjartsson DF, et al. (2002) BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. J Clin Oncol 20: 2701-2712.

    Google Scholar 

  13. Breast Cancer Risk Assessment Tool. http://brca.nci.nih.gov/brc.

  14. Rockhill B,Spiegelman D,Byrne C,Hunter DJ,Colditz GA (2001) Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. J Natl Cancer Inst 93: 358-366.

    Google Scholar 

  15. Edwards A,Elwyn G,Mulley A (2002) Explaining risks: turning numerical data into meaningful pictures. BMJ 324: 827-830.

    Google Scholar 

  16. Couch FJ,DeShano ML,Blackwood MA, et al. (1997) BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 336: 1409-1415.

    Google Scholar 

  17. Berry DA,Parmigiani G,Sanchez J,Schildkraut J,Winer E (1997) Probability of carrying a mutation of breast-ovarian gene BRCA1 based on family history. J Natl Cancer Inst 89: 227-238.

    Google Scholar 

  18. Bluman LG,Rimer BK,Berry DA, et al. (1999) Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2. J Clin Oncol 17: 1040-1046.

    Google Scholar 

  19. Dorval M,Patenaude AF,Schneider KA, et al. (2000) Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 programs. J Clin Oncol 18: 2135-2142.

    Google Scholar 

  20. Lerman C,Hughes C,Lemon SJ, et al. (1998) What you don't know can hurt you: adverse psychologic effects in members of BRCA1-linked and BRCA-2 linked families who decline genetic testing. J Clin Oncol 16: 1650-1654.

    Google Scholar 

  21. Lerman C,Hughes C,Croyle RT, et al. (2000) Prophylactic surgery decisions and surveillance practices one year following BRCA1/2 testing. Prev Med 31: 75-80.

    Google Scholar 

  22. Degner LF,Kristjanson LJ,Bowman D, et al. (1997) Information needs and decisional preferences in women with breast cancer. JAMA 277: 1485-1492.

    Google Scholar 

  23. Ravdin PM,Siminoff IA,Harvey JA (1998) Survey of breast cancer patients concerning their knowledge and expectations of adjuvant therapy. J Clin Oncol 16: 515-521.

    Google Scholar 

  24. Bluman LG,Borstelmann NA,Rimer BK, et al. (2001) Knowledge, satisfaction, and perceived cancer risk among women diagnosed with ductal carcinoma in situ. J Women Health Gend Based Med 10: 589-598.

    Google Scholar 

  25. O'Connor AM,Fiset V,DeGrasse C, et al. (1999) Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. J Natl Cancer Inst Monogr 25: 67-80.

    Google Scholar 

  26. Levine MN,Gafni A,Markham B,MacFarlane D (1992) A bedside decision instrument to elicit a patient's preference concerning adjuvant chemotherapy for breast cancer. Ann Intern Med 117: 53-58.

    Google Scholar 

  27. Whelan TJ,Levine MN,Gafni A, et al. (1995) Breast irradiation postlumpectomy: development and evaluation of a decision instrument. J Clin Oncol 13: 847-853.

    Google Scholar 

  28. Goel V,Sawka CA,Thiel EC,Gort EH,O'Connor AM (2001) Randomized trial of a patient decision aid for choice of surgical treatment for breast cancer. Med Decis Making 21: 1-6.

    Google Scholar 

  29. Ravdin PM,Siminoff LA,Davis GJ, et al. (2001) Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer. J Clin Oncol 19: 980-991.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Ambulatory Care and Prevention, Harvard Medical School/Harvard Pilgrim Health Care, Boston, MA (LN), USA

    Larissa Nekhlyudov

  2. Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA (AP), USA

    Larissa Nekhlyudov

  3. Harvard Medical School, Dana-Farber Cancer Institute, Boston, MA (LN, AP), USA

    Ann Partridge

Authors
  1. Larissa Nekhlyudov
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ann Partridge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Larissa Nekhlyudov.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nekhlyudov, L., Partridge, A. Breast cancer risk communication: challenges and future research directions: workshop report (United States). Cancer Causes Control 14, 235–239 (2003). https://doi.org/10.1023/A:1023684230438

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1023684230438

Search

Navigation